Comparative analysis on the anti-inflammatory/immune effect of mesenchymal stem cell therapy for the treatment of pulmonary arterial hypertension

por Seyeon Oh, Albert Y. Jang, Sehyun Chae, Seungbum Choi, Jeongsik Moon, Minsu Kim, Edda Spiekerkoetter, Roham T. Zamanian, Phillip C. Yang, Daehee Hwang, Kyunghee Byun, Wook-Jin Chung
Publicado 2021

Prescription Patterns for Pulmonary Vasodilators in the Treatment of Pulmonary Hypertension Associated With Chronic Lung Diseases: Insights From a Clinician Survey

por Christopher A. Thomas, Justin Lee, Roberto J. Bernardo, Ryan J. Anderson, Vladimir Glinskii, Yon K. Sung, Kristina Kudelko, Haley Hedlin, Andrew Sweatt, Steven M. Kawut, Rishi Raj, Roham T. Zamanian, Vinicio de Jesus Perez
Publicado 2021

TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension

por Robert P. Frantz, Raymond L. Benza, Richard N. Channick, Kelly Chin, Luke S. Howard, Vallerie V. McLaughlin, Olivier Sitbon, Roham T. Zamanian, Anna R. Hemnes, Matt Cravets, Jean-Marie Bruey, Robert Roscigno, David Mottola, Erin Elman, Lawrence S. Zisman, Hossein-Ardeschir Ghofrani
Publicado 2021